Sabra (SBRA) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - Sabra Healthcare (SBRA) reported revenue of $190.04 million for Q3 2025, marking a year-over-year increase of 6.8% and an EPS of $0.38, up from $0.13 a year ago, but fell short of the Zacks Consensus Estimate of $192.12 million by -1.08% [1] Financial Performance - Rental and related revenues were reported at $85.35 million, which is -9.7% lower than the estimated $97.66 million [4] - Resident fees and services generated $92.02 million, exceeding the average estimate of $81.13 million, reflecting a year-over-year increase of +24.8% [4] - Interest and other income amounted to $12.67 million, surpassing the estimated $10.21 million, with a year-over-year change of +30.6% [4] - Net Earnings Per Share (Diluted) were reported at $0.09, below the average estimate of $0.19 [4] Market Performance - Over the past month, Sabra's shares returned -0.2%, while the Zacks S&P 500 composite increased by +1% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]